IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study

被引：0
|
作者：
Hong Ye
Guo-ning Huang
Ping-hong Zeng
Li Pei
机构：
[1] Chongqing Reproductive and Genetic Institute,
[2] Chongqing Obstetric and Gynecology Hospital,undefined
[3] Chongqing Reproductive and Genetic Institute,undefined
[4] Chongqing Obstetric and Gynecology Hospital,undefined
来源：
Journal of Assisted Reproduction and Genetics | 2009年 / 26卷
关键词：
FSH; Estradiol pre-treatment; Controlled ovarian hyperstimulation; IVF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：105 / 111
页数：6
相关论文
共 43 条
  • [1] IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study
    Ye, Hong
    Huang, Guo-ning
    Zeng, Ping-hong
    Pei, Li
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2009, 26 (2-3) : 105 - 111
  • [2] Long term pretreatment with GnRH agonist before standard GnRH agonist protocol for adenomyosis in IVF/ICSI fresh embryo transfer cycles
    Chen, M. H.
    Luo, L.
    Zhang, X.
    Gao, J.
    Qiong, W.
    Zhou, C.
    [J]. HUMAN REPRODUCTION, 2017, 32 : 257 - 257
  • [3] GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles:: a prospective randomized study
    Humaidan, P
    Bredkjær, HE
    Bungum, L
    Bungum, M
    Grondahl, ML
    Westergaard, L
    Andersen, CY
    [J]. HUMAN REPRODUCTION, 2005, 20 (05) : 1213 - 1220
  • [4] GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study
    Engmann, L
    Benadiva, C
    [J]. HUMAN REPRODUCTION, 2005, 20 (11) : 3258 - 3260
  • [5] Reply: GnRH agonist (buserelin) or hCG for ovulation induction in gnRH antagonist IVF/ICSI cycles: a prospective randomized study
    Humaidan, P
    [J]. HUMAN REPRODUCTION, 2005, 20 (11) : 3260 - 3260
  • [6] IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial
    Haydardedeoglu, Bulent
    Kilicdag, Esra Bulgan
    Parlakgumus, Ayse Huriye
    Zeyneloglu, Hulusi Bulent
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (03) : 763 - 769
  • [7] IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial
    Bulent Haydardedeoglu
    Esra Bulgan Kilicdag
    Ayse Huriye Parlakgumus
    Hulusi Bulent Zeyneloglu
    [J]. Archives of Gynecology and Obstetrics, 2012, 286 : 763 - 769
  • [8] Long GnRH agonist protocol versus GnRH antagonist protocol in high responder patients undergoing IVF: A prospective cohort study.
    Farhi, J.
    Ben-Haroush, A.
    Weissman, A.
    Nahum, H.
    Levran, D.
    [J]. FERTILITY AND STERILITY, 2006, 86 : S411 - S412
  • [9] GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study
    Ata, B.
    Yakin, K.
    Balaban, B.
    Urman, B.
    [J]. HUMAN REPRODUCTION, 2008, 23 (03) : 668 - 673
  • [10] Use of steroid pre-treatments in IVF-ICSI cycles with GnRH antagonist protocol and their impact on gestational outcomes
    Fernandez-Prada, Sara
    Martin-Camean, Maria
    Armijo, Onica
    Diez-Sebastian, Jesus
    Iniesta, Silvia
    Lobo, Sonia
    Silva, Patricia
    Sanz, Clara
    Jose Sanchez, Maria
    Hernandez, Alicia
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (03) : 478 - 484
12345